Breast cancer significantly impacts a person's life, requiring them to make numerous critical decisions about care, support, and their personal life. The introduction of risk-based breast cancer screening necessitates active engagement, effective communication, and robust support from stakeholders.
In this webinar, Dr Lippey will illustrate how decision aids can enhance the acceptance of this transition and play a crucial role in facilitating informed decision-making.
Additionally, understanding the perspectives of program administrators is essential, as careful assessment is required during the planning phase of this change. Dr Lippey's presentation will discuss how employing an implementation framework can identify key issues relevant to stakeholders before initiating this shift.
Dr Jocelyn Lippey is in the final year of her PhD addressing communication and education around risk stratified breast screening for consumers, for which she is a current RACS Gloria and Herbert Keys scholarship recipient, as well as a previous recipient of an NBCF practitioners grant. She is Chief Investigator on the BRAIx project which is assessing the use of artificial intelligence to improve breast cancer screening. Dr Lippey is a member of BreastCancer Trials Scientific Advisory Committe and sits on the board of BreastScreen Victoria. She is also a proud co-creator of the breast unit database at St. Vincent's which collects integrated patient-reported outcome measures for all cancer patients undergoing surgery.
